Caris Life Sciences, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $292,887 | $216,833 | $181,398 | $120,915 |
Gross Profit | 220,914 | 147,506 | 113,685 | 57,063 |
EBITDA | 90,429 | 42,702 | -46,173 | -82,754 |
EBIT | 83,384 | 37,832 | -52,582 | -89,799 |
Net Income | 81,957 | 24,325 | -71,790 | -102,581 |
Net Change In Cash | 292,887 | 216,833 | 181,398 | 120,915 |
Free Cash Flow | 5,663 | 55,330 | 5,902 | -34,027 |
Cash | 797,799 | 753,221 | 718,934 | 31,201 |
Basic Shares | 1,672,056 | 297,211 | 276,000 | 254,788 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $812,033 | $412,260 | $306,128 | $258,485 |
Gross Profit | 539,168 | 178,782 | 89,310 | 80,022 |
EBITDA | 11,380 | -182,952 | -260,804 | -245,894 |
EBIT | -11,235 | -231,865 | -309,805 | -294,147 |
Net Income | -537,957 | -281,890 | -341,415 | -320,827 |
Net Change In Cash | 812,033 | 412,260 | 306,128 | 258,485 |
Free Cash Flow | 66,895 | -253,643 | -298,419 | -327,961 |
Cash | 797,799 | 63,950 | 56,402 | 107,191 |
Basic Shares | 1,672,056 | 254,662 | 254,662 | 254,788 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.28 |
2025-09-30 | $0.08 |
2025-06-30 | -$1.11 |
2025-03-31 | -$0.35 |
